March 6, 2026
Put Patients First by Studying the 340B Program
Established by Congress in 1992, the 340B Drug Pricing Program was intended to help safety-net providers improve access to healthcare for low-income,…
Read MoreMarch 3, 2026
CCPA Submits Comments on IPAY 2028 Selections
On March 1, 2026, Chronic Care Policy Alliance (CCPA) submitted formal comments to the Centers for Medicare & Medicaid Services…
Read MoreMarch 3, 2026
CCPA Submits Comments on Proposed Medicare Drug Pricing Models
Chronic Care Policy Alliance (CCPA) submitted comments to the Centers for Medicare & Medicaid Services (CMS) regarding the proposed GLOBE…
Read MoreJanuary 27, 2026
CCPA Responds to CMS Drug Price Negotiation Announcement (IPAY 2028)
Liz Helms, Founder and Director of the Chronic Care Policy Alliance (CCPA), issued the following statement in response to the…
Read MoreAugust 1, 2025
340B Bill Successfully Halted in California for 2025
In California, as in many states, a bill expanding the 340B program — AB 1460 — was causing deep concerns…
Read MoreJuly 31, 2025
CCPA Shares Mid-Year Priorities with the Administration and Key Congressional Committees
As part of our continued advocacy for the chronic disease community, the Chronic Care Policy Alliance (CCPA) has submitted letters…
Read MoreJuly 1, 2025
CCPA Urges CMS to Strengthen Patient Engagement and Safeguards in Medicare Drug Price Negotiation Program
Today, CCPA submitted comments to the Centers for Medicare and Medicaid Services (CMS) in response to its draft guidance for…
Read MoreMay 22, 2025
Forecast 2025
Forecast 25 brought together advocates from 10 states and included, health care professionals, policy leaders, and community partners, all united…
Read MoreMay 8, 2025
CCPA Submits Sign-On Letter to Administration Opposing Tariffs on Pharmaceuticals
The Chronic Care Policy Alliance, joined by 32 other organizations, submitted the following letter to the US Department of Commerce’s…
Read MoreMarch 18, 2025
Chronic Care Policy Alliance Applauds House Lawmakers for Extending Telehealth Flexibilities, Urges Further Steps to Protect Patient Access
Liz Helms, Founder and Director of the Chronic Care Policy Alliance (CCPA), issued the following statement in response to Congress’…
Read MoreMarch 4, 2025
CCPA Provides Comments in Second Round of Medicare Drug Pricing
The Chronic Care Policy Alliance (CCPA) submitted comprehensive comments to the Centers for Medicare & Medicaid Services (CMS) regarding all…
Read MoreDecember 11, 2024
Chronic Care Policy Alliance Urges Congress to Pass PBM Reform, Telehealth Extension, and MCED Legislation Now
(SACRAMENTO, CA) – Liz Helms, Founder and Director of the Chronic Care Policy Alliance (CCPA), issued the following urgent statement…
Read MoreAugust 15, 2024
CCPA Statement on CMS Drug Price Negotiation Announcement
“While we share the administration’s goal of lowering drug costs, we remain concerned that the drug negotiation process may do more harm…
Read MoreJuly 18, 2024
Advocating for Patient Voices: CCPA’s Letters to CMS on Medicare Drug Price Negotiations
The Chronic Care Policy Alliance (CCPA) is continuing to advocate for policies that prioritize patient needs and ensure their voices…
Read MoreJune 28, 2024
H.R. 2407 passes unanimously through House Ways and Means Committee
The House Ways and Means Committee unanimously voted to advance H.R. 2407: The Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act!…
Read More